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Abstract
Background: Adhesion to extracellular matrix (ECM) components has been implicated in the
proliferative and invasive properties of tumor cells. We investigated the ability of C6 glioma cells
to attach to ECM components in vitro and described the regulatory role of glycosaminoglycans
(GAGs) on their adhesion to the substrate, proliferation and migration.
Results: ECM proteins (type IV collagen, laminin and fibronectin) stimulate rat C6 glioma cell line
adhesion in vitro, in a dose-dependent manner. The higher adhesion values were achieved with type
IV collagen. Exogenous heparin or chondroitin sulfate impaired, in a dose-dependent manner the
attachment of C6 glioma cell line to laminin and fibronectin, but not to type IV collagen. Dextran
sulfate did not affect C6 adhesion to any ECM protein analyzed, indicating a specific role of GAGs
in mediating glioma adhesion to laminin and fibronectin. GAGs and dextran sulfate did not induce
C6 glioma detachment from any tested substrate suggesting specific effect in the initial step of cell
adhesion. Furthermore, heparin and chondroitin sulfate impaired C6 cells proliferation on
fibronectin, but not on type IV collagen or laminin. In contrast, both GAGs stimulate the glioma
migration on laminin without effect on type IV collagen or fibronectin.
Conclusion: The results suggest that GAGs and proteoglycans regulate glioma cell adhesion to
ECM proteins in specific manner leading to cell proliferation or cell migration, according to the
ECM composition, thus modulating tumor cell properties.
Background
Glioblastoma multiforme (GBM) is the most common
malignant form of glioma, and resistant to therapeutic
interventions, causing most patients to die within 1 year
after diagnosis[1]. The rat C6 glioma cell line, originally
produced by Wistar-Furth rats exposed to N,N'-nitroso-
methylurea, is morphologically similar to GBM when
injected into brain of rats and has been used as both in
vivo  and  in vitro model for the study of this kind of
tumor[2].
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Extracellular matrix (ECM) components control many
aspects of cell behavior, such as differentiation, prolifera-
tion, cell morphology and attachment[3]. It has been sug-
gested that adhesion to ECM in vivo and in vitro is involved
in the earlier steps of tumor progression, resulting in
genomic instability which allows for the accumulation of
multiple mutations[4]. Transformation of cells is fre-
quently accompanied by a change in adhesive properties,
often resulting in a decreased adhesion of these cells[4].
Moreover, glioma proliferation and migration can be
modulated by adhesion to different substrates [5-8] and
they have been suggested as mutually exclusive behavior
in astrocytoma cell lines[9]. In particular, C6 glioma cells
have been shown to secrete laminin-2[10], and upon
nerve growth factor stimulation, tenascin and fibronec-
tin[11]. Integrins, the receptors to ECM proteins, partici-
pate in and regulate cell-substrate adhesion[4]. Adhesion
to ECM proteins could direct integrin signaling with sub-
sequent activation of cytoplasmic tyrosine kinases and
induction of downstream effector pathways[12]. It has
been shown that C6 glioma cells express the well-charac-
terized fibronectin (α5β1) and the multi-specific laminin,
collagens and fibronectin (α3β1) receptors[13]. Neverthe-
less, the function of individual ECM components, their
involvement in cell adhesion as well as the molecular
processes mediating growth and invasion of malignant
gliomas are not properly characterized.
Several experimental evidences suggest that cell surface
proteoglycans are also involved in tumor growth and pro-
gression. Highly sulfated glycosaminoglycans (GAGs) and
the sulfated polysaccharide fucoidan, stimulate
melanoma cell invasion in vitro[14]. On the other hand,
inhibition of GAGs' sulfation promoted by sodium chlo-
rate treatment reduced the proliferation and adhesion of
the leukemic cell line WeHi-3B[15] and C6 glioma
cells[16]. Moreover, heparan sulfate proteoglycans have
been suggested to play a role in cell adhesion as positive
modulators of cell proliferation in Chinese hamster ovary
cells[17].
In the present study we have evaluated the role of ECM
components in the adhesion, of glioma cells in vitro. We
report that the addition of the GAGs, heparin and chon-
droitin sulfate affected C6 cells adhesion to laminin and
fibronectin in a specific way in contrast to type IV colla-
gen. In contrast, C6 glioma detachment from these ECM
proteins was not altered by GAGs. We also demonstrate
an involvement of heparin and chondroitin sulfate in reg-
ulating glioma proliferation and migration on ECM pro-
teins. The results suggest a role of GAGs and proteoglycans
in regulating glioma adhesion to ECM components as
well as proliferation and migration according to the ECM
composition.
Results
The three ECM proteins analyzed, type IV collagen, lam-
inin and fibronectin, induced C6 cell adhesion in a dose-
dependent manner (Figure 1A). At the lower ECM concen-
tration (2 µg/ml), C6 cells presented greater adhesion to
type IV collagen that was significantly higher (160%) than
control (absence of ECM). In contrast, 2 µg/ml of
fibronectin or laminin did not display considerable effect
on cell adhesion. However, at the concentration of 4 µg/
ml, both type IV collagen and fibronectin significantly
stimulated C6 cell adhesion (+171% and +133%, respec-
tively) whereas laminin did not affect it. All three ECM
proteins presented the maximum adhesion effect at 10 µg/
ml, after which a plateau was reached. At this concentra-
tion, type IV collagen improved C6 cell adhesion in
203%, fibronectin in 193%, and laminin in 105%. Lam-
inin was the less adhesive substrate to C6 cells in all con-
centrations analyzed. Similar adherence activity of C6
cells were observed in the absence of ECM molecule and
with BSA only (data not shown).
In order to analyze if GAGs could control C6 attachment
to ECM molecules, we performed adhesion assays in the
presence of heparin or chondroitin sulfate (Figure 1B, C).
The addition of heparin significantly impaired cellular
attachment to both laminin and fibronectin in a dose-
dependent manner (Figure 1B). The higher heparin con-
centration (5 mg/ml) promoted 42% of inhibition in C6
cell adhesion to laminin and 42% to fibronectin. No
inhibitory effect was observed in the attachment to type IV
collagen. We also analyzed the attachment of C6 cells to
ECM proteins in presence of commercial chondroitin sul-
fate to verify if other GAG could have similar effects as
observed for heparin (Figure 1C). Interestingly, the addi-
tion of chondroitin sulfate inhibited C6 adhesion to lam-
inin and fibronectin in a dose dependent manner,
similarly to heparin. The higher chondroitin sulfate con-
centration (5 mg/ml) produced inhibition of 33.2% in C6
cell adhesion to laminin and 31.4% to fibronectin. Chon-
droitin sulfate did not affect C6 cell attachment to type IV
collagen. In addition, both heparin and chondroitin sul-
fate did not significantly alter C6 adhesion in the absence
of ECM molecules, to culture dish plastic (100% ± 10 and
105% ± 8 of adhesion at 5 mg/ml, respectively) or BSA-
coated well (92% ± 7 and 95% ± 9 of adhesion at 5 mg/
ml, respectively). After that, we investigated the influence
of dextran sulfate on C6 adhesion, as a control polyanion
(Figure 1D). Dextran sulfate did not alter C6 cells attach-
ment to any ECM protein analyzed. C6 cells adhesion to
the culture dish plastic or BSA-coated well were also not
affected by dextran sulfate (95% ± 10 and 99% ± 11 at 5
mg/ml, respectively). The results could suggest that
heparin and chondroitin sulfate are involved in C6 gli-
oma adhesion to fibronectin and laminin in a specific
way. Nevertheless, these GAGs seems do not affect gliomaBMC Cell Biology 2005, 6:31 http://www.biomedcentral.com/1471-2121/6/31
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adhesion to collagen IV. These findings could be
explained by the presence of proteoglycan binding sites in
fibronectin and laminin molecules but not to
collagen[18].
To further verify the involvement of GAGs in the modula-
tion of glioma interaction with substrate, we analyzed cel-
lular detachment (Table 1). It is interesting to note that
the addition of GAGs and dextran sulfate (alone or in
combination) to C6 cells attached to ECM molecules did
not induce cell detachment. GAGs and dextran sulfate
also have not effect on glioma detachment from culture
dish plastic or BSA coated wells. Taken together, the
results could suggest that heparin and chondroitin sulfate
specifically regulate the initial phase of C6 cells adhesion
to the substrate composed of laminin and fibronectin,
perhaps in the organization or stabilization of focal con-
tacts. However, these GAGs seem do not display signifi-
cant effect after the complete cellular attachment.
We hypothesized if heparin and chondroitin sulfate treat-
ment of C6 glioma cells adhesion could somewhat be
related to modifications in cell proliferation. To test this
we analyzed C6 cells proliferation when cultured on ECM
proteins in the presence of these GAGs (Figure 2). We
observed that heparin significantly reduced C6 cell prolif-
eration on fibronectin as substrate at about 24% C6 in all
concentrations analyzed (Figure 2A). In contrast, this
Glycosaminoglycans (GAGs) Effects on C6 Glioma Adhesion to extracellular matrix (ECM) proteins Figure 1
Glycosaminoglycans (GAGs) Effects on C6 Glioma Adhesion to extracellular matrix (ECM) proteins. (A) Dose dependency of 
C6 glioma adhesion to ECM-coated wells. Wells were coated with different concentrations of type IV collagen (Col IV), Lam-
inin (Ln) or Fibronectin (Fn). Adhesion assays were performed as described in Methods. Results, expressed in Absorbance at 
540 nm, were compared with the adhesion in the absence of ECM. Each point represents the mean of four independent exper-
iments performed in triplicate ± SD. Effects of (B) Heparin, (C) chondroitin sulfate and (D) dextran sulfate on C6 Cells adhe-
sion to ECM proteins. Results were compared with cells seeded on ECM substrate only (controls: 100%). Stars in B and C are 
equivalent for adhesion on laminin or fibronectin. Each point represents the mean of four independent experiments performed 
in triplicate ± SD. **p < 0.001, ***p < 0.0001 when compared to controls.
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GAG did not alter glioma proliferation when cultured on
type IV collagen or laminin coated wells. The effects of
chondroitin sulfate treatment on C6 cells proliferation
were similar to that of heparin (Figure 2B). Chondroitin
sulfate significantly impaired about 20% C6 cell prolifer-
ation on fibronectin in a similar proportion at the three
concentrations tested. On the other hand, cell prolifera-
tion on laminin and type IV collagen was not altered. In
addition, both heparin and chondroitin sulfate did not
affect C6 cell proliferation in the absence of ECM mole-
cules (data not shown).
Afterward, we investigated if GAGs also affect C6 glioma
migration on ECM (Figure 3). To eliminate possible influ-
ence of proliferation, we established as nine hours as time
limit in migration assay. The C6 glioma cells migration on
different substrates increased over time. Amongst the
ECM proteins, type IV collagen was the most effective in
inducing C6 cells migration, followed by fibronectin, and
subsequently by laminin. The addition of heparin or
chondroitin sulfate at tested concentrations (50 or 100
mg/ml) did not alter cell migration on both type IV colla-
gen (Figure 3A) and fibronectin (Figure 3B). In contrast,
these GAGs significantly increased cell migration on lam-
inin substrate different proportions according to the dose
(Figure 3C). The most prominent effect was observed at
time point of six hour when heparin increased cell migra-
tion in 222% and 567% 50 and 100 mg/ml, respectively,
when compared to the control (without GAG). At this
time point, chondroitin sulfate also presented expressive
effect in stimulating cell migration (+166% and +373% at
50 and 100 mg/ml, respectively). C6 cell migration with-
out ECM proteins was not affected by both GAGs (data
not shown).
Discussion
Tumor-stroma interactions play a pivotal role in regula-
tion tumor progression and malignance[19]. We had
shown previously that undersulfation of GAGs reduces
the proliferation of the leukemic cell line Wehi 3B[15]
and C6 glioma cells[16] suggesting a regulatory role of
proteoglycans on cellular processes involved in tumor
progression. We report here that GAGs are also involved
in the control of glioma cell adhesion, proliferation and
migration on ECM proteins.
It has long been appreciated that some of the earliest steps
of neoplastic transformation involve changes in tissue
interaction, including alterations in cell adhesion. Loss of
cell adhesion was postulated as involved in genomic
instability and related to the invasive behavior and motil-
ity of malignant cells[4]. Among ECM proteins, laminin
was shown as the most potent stimulator of glioma migra-
tion and invasion[10,20]. In particular, laminin mediate
C6 glioma cells invasion both in vitro and in vivo [10].
Mahesparan and co-workers[20] reported that laminin
was the most efficient ECM protein in inducing cell migra-
tion of three different human glioma cell lines (U-373
MG, A-172 MG and HF-66), followed by fibronectin,
while type IV collagen did not promote cell migration. In
our experiments, however, we observed an inverse corre-
lation with rat C6 glioma regarding both adhesion and
Table 1: GAGs effects on C6 Glioma detachment
Substrate GAG % Detachment
Type IV Collagen Heparin 0% ± 0.14
Chondroitin Sulfate 7.5 % ± 0.7
Dextran Sulfate 0% ± 0.2
Fibronectin Heparin 5% ± 0.9
Chondroitin Sulfate 4% ± 0.6
Dextran Sulfate 0% ± 0.2
Laminin Heparin 0% ± 0.9
Chondroitin Sulfate 0% ± 0.12
Dextran Sulfate 0% ± 0.5
Culture dish plastic Heparin 7% ± 0,2
Chondroitin Sulfate 5% ± 0,1
Dextran Sulfate 2% ± 0,3
BSA Heparin 0% ± 0.1
Chondroitin Sulfate 5% ± 0,7
Dextran Sulfate 4% ± 0,4
Wells were coated with 10 µg/ml of type IV collagen, Fibronectin or Laminin. Detachment assays were performed as described. Results were 
compared with cells seeded on ECM substrate only. Coating with BSA or the culture dish plate was used as controls. Each point represents the 
mean of three independent experiments performed in triplicate ± SD.BMC Cell Biology 2005, 6:31 http://www.biomedcentral.com/1471-2121/6/31
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migration: type IV collagen was the most potent substrate,
followed by fibronectin and somewhat weaker
attachment and migration on laminin. It is possible that
the different adhesion ability of C6 cells to ECM proteins
may be related to its migratory capacity.
For cell adhesion and migration, specific cell surface
receptors that interact with ECM components are needed.
Cell-surface heparan sulfate[21] or chondroitin sul-
fate[18] proteoglycans have been implicated in cell
attachment via interactions with ECM proteins, such as
laminin and fibronectin, and integrins. The syndecan
family of transmembrane proteoglycans can act as co-
receptors to modulate integrin-mediated cell-matrix adhe-
sion. Together with integrins, they form a dual receptor
system active in cell-matrix adhesion[22]. Cell attachment
Effects of (A) Heparin and (B) chondroitin sulfate on C6 Cells  proliferation Figure 2
Effects of (A) Heparin and (B) chondroitin sulfate on C6 Cells 
proliferation. Wells were coated with 10 µg/ml of type IV 
collagen (Col IV), Laminin (Ln) or Fibronectin (Fn). Prolifera-
tion assay was performed by MTT test as described in Meth-
ods. Each point represents the mean of three independent 
experiments performed in triplicate ± SD. **p < 0.001 when 
compared to cells seeded on ECM substrate only (controls: 
100%).
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and spreading can be promoted through integrin interac-
tions with the integrin-binding domain of fibronectin.
Additional binding of a heparin-binding domain of
fibronectin to a cell surface heparan sulfate proteoglycans
(HSPG) promotes focal adhesion formation by activating
PKC[23]. The HSPG involved appears to be exclusively
syndecan-4[23] that binds to fibronectin via its GAG side
chains[24].
Several studies have suggested that cell surface proteogly-
cans are involved in the control of glioma cell growth,
adhesion and invasion. The chondroitin sulfate lectican
BEHAB is up-regulated in malignant gliomas and derived
cell lines, and was proposed to play a role in brain tumor
invasion[19]. C6 glioma cells transfected with appican
display dramatic change in their phenotypic appearance
as well as increased cell adhesion [25]. In addition, we
have previously demonstrated that sodium chlorate treat-
ment, an inhibitor of GAG's sulfation, reduces C6 cells
proliferation and adhesion to ECM proteins further sug-
gesting that cell surface highly sulfated components act as
co-receptor for glioma cell attachment to ECM[16]. In the
present paper, we observed that the addition of heparin or
chondroitin sulfate to the culture dish together within
cells impaired C6 adhesion affecting the earliest steps of
C6 cell adhesion, possibly due to the competition with
GAG chains of cell surface proteoglycans to fibronectin
and laminin binding sites. We could suggest that the spe-
cific interactions of GAGs with fibronectin and laminin
affect the organization of focal adhesions necessary to
promote cell adhesion. In contrast, addition of heparin or
chondroitin sulfate after cells completely attached to sub-
strate did not promote cell detachment possibly because
focal adhesion points were already established and the
addition of GAGs were not sufficient to disturb them. In
fact, it has been reported that ECM ligands bind to
heparan sulfate proteoglycans and produce actin filament
reorganization even in the absence of integrin occu-
pancy[26]. The interactions of heparan sulfate chains with
extracellular ligands may help the formation of proteogly-
can clusters, which appears to be critical for focal adhe-
sion formation[26].
Moreover, it was reported that cell growth is anchorage
dependent[27]. Thus, the reduction in C6 cell prolifera-
tion on fibronectin promoted by heparin and chondroitin
sulfate observed in our experiments could be consequence
of the altered cell adhesion. In addition, highly sulfated
GAGs, heparin and heparan sulfate, and sulfated polysac-
charide, fucoidan, have been reported stimulating tumor
cell invasion in vitro, due to a stimulation of the proteo-
lytic cascade of plasminogen activation[14]. This suggests
that sulfated GAGs liberated by tumor cells, mediate ECM
degradation amplifying pericellular plasminogen activa-
tion and locally enhancing tumor cell invasion in a posi-
tive feedback. In our experiments we observed that both
chondroitin sulfate and heparin induced C6 cell migra-
tion on laminin substrate in different proportions accord-
ing to the dose, with the most prominent effect at the fist
6 hours. These results are consistent with the influence of
the GAGs on the earliest steps of cell adhesion to ECM
proteins (Figure 1 and Table 1). It is possible that GAGs
induce the organization of adhesion contacts in C6 cells
that specifically lead to proliferation or migration when
maintained on fibronectin or laminin, respectively.
Conclusion
One of the fundamental properties of pericellular prote-
oglycans is to interact with other molecules, thereby mod-
ulating cell adhesion, proliferation, and differentiation or
the structural characteristics of tissues[22]. Indeed, we
suggest that cell surface proteoglycans may function as
coordinators of glioma cell interactions to microenviron-
ment possible acting in the organization focal adhesions.
Specific interactions of cell surface proteoglycans with
ECM proteins may differently control glioma cell adhe-
sion leading to alterations in proliferation or migration.
Methods
C6 glioma cell culture
The rat glioblastoma C6 cell line were a gift from Dr. Viv-
aldo Moura Neto (Universidade Federal do Rio de Janeiro,
Rio de Janeiro, Brazil) and cultured as previously
described[16]. Cells were grown in Dulbecco's modified
Eagle's medium (DMEM, Sigma, St. Louis) supplemented
with 5% fetal calf serum (Fazenda Pigue, Brazil), 100 mg/
ml streptomycin and 100 U/ml penicillin (all from
Sigma) in a humidified incubator at 37°C in a 5% CO2,
95% air atmosphere (standard conditions). Cells were
harvested with 0.125% trypsin/0,78 mM EDTA, when
they reached confluence.
ECM coating and adhesion assay
Culture plates (Corning, NY, USA; 96 well) were coated
with mouse type IV collagen, laminin or fibronectin
(Gibco BRL, Grand Island, NY; 2 to 20 µg/ml) dissolved
in phosphate buffered saline (PBS) pH 7.4 (12 hours,
4°C). Wells were washed with PBS, blocked with 2% BSA
in PBS (1 hour, 37°C). Cellular adhesion was performed
as previously described[16]. Briefly, cells were detached
by trypsinization, washed in PBS, suspended in DMEM
and seeded into ECM-coated 96-well plates (105 cells/
well). After 2 hours of incubation under standard culture
conditions, the non-adherent cells were removed by PBS
washing. Attached cells were fixed (4% paraformalde-
hyde) and stained with 0.5% crystal violet dissolved in
20% methanol. The plates were then washed (PBS) and
stain was eluted from cells with 0.1 M sodium citrate, pH
4.2 in 50% ethanol. The amount of stain was analyzed by
optical density (OD) in ELISA wells microplate readerBMC Cell Biology 2005, 6:31 http://www.biomedcentral.com/1471-2121/6/31
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(Model ELX800, Bio-Tek Instruments) at 540 nm. In some
experiments heparin, chondroitin sulfate or dextran sul-
fate (all from Sigma, 1 to 5 mg/ml) were added to the
attachment medium at the same time as C6 cells were
inoculated to the plates previously coated with 10 µg/ml
of type IV collagen, laminin or fibronectin. For the detach-
ment assays, cells were prepared as for the adhesion exper-
iment, seeded on ECM-coated wells (5 × 104 cells/well)
and incubated for 3 h in standard culture condition when
most of them were attached. After PBS washing, 5 mg/ml
of heparin, chondroitin sulfate or dextran sulfate were
added and the cultures were incubated for additional 2
hours in standard conditions. Wells were them washed,
and the attached cells fixed, stained and processed as
described for adhesion assays. Cell detachment was calcu-
lated by the difference from the percentage of adherent
cells in relation to controls (ECM-coated well without
GAG).
MTT assay
This method has been extensively used to determine glial
cell proliferation[16,28,29]. C6 cells were plated (104 cell/
well) in 96-well culture plates previously coated with 10
µg/ml ECM proteins as described above in the presence of
heparin or chondroitin sulfate (1 to 3 mg/ml) and cul-
tured for 2 days. Viable cells were quantified by MTT
colorimetric assay for mitochondrial dehydrogenase[30].
Migration assay
A monolayer migration assay was used to quantify loco-
motion of C6 cells on ECM. Cells (1.5 × 105) were seeded
into 13 mm coverslips. After overnight incubation in
standard culture conditions, coverslips containing conflu-
ent monolayers were transferred to the center of 35 mm
wells (with cells up) previously coated with 10 µg/ml of
ECM proteins as described above. Fresh DMEM contain-
ing heparin or chondroitin sulfate (1 to 3 mg/ml) was
added. Cells were maintained in standard culture condi-
tions except during brief microscopic examinations.
Migration was calculated by serial measurements of the
ratio beyond the initial cell population (cells that migrate
out of the coverslip to ECM substrate). The analysis were
performed at 0, 6, and 9 hours, using a micrometric ocular
(Olympus) attached to an Olympus CK 40 microscope.
Statistical analysis
The significance of differences was evaluated by means of
One-way ANOVA with Newman-Keuls or Dunnett as
post-tests using the GraphPad InStat program (San Diego
California USA).
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